Global Access to Medical Innovation

• Build global access expertise by educating SIG members and external stakeholders on the nature and cost of financing innovative medical research and development (R&D), and particularly promote an understanding of the functioning and impact of the complex nature of market access in the US and its global implications.
• Promote global information-sharing about the clinical and economic value of new medical innovations to facilitate more rapid access across countries, particularly low-and middle-income countries (LMICs).
• Explore global market design reforms or innovation that would support more efficient and equitable global financing of R&D for medical innovation, starting with differential (or tiered) pricing value-based arrangements.

This SIG aims to address not only new patent-protected medicines and vaccines, but also other technologies such as diagnostics, devices, procedures, information technologies, digital technologies, etc. under the following observations:

• Understanding The Global Access Ecosystem
• Non-Exclusivity of Medical Innovation
• Low Marginal Cost of Medical Innovation
• Medical Innovation Cascade Follows Financing Flow